ICTO 2026 – International Conference on Clinical & Translational Oncology

 The 9th Edition of International Conference on Clinical & Translational Oncology (ICTO 2026) will take place on October 8–10, 2026, in Tokyo, Japan, with an option for participants to join virtually as part of the hybrid conference organized by Magnus Group.

From Prevention to Survivorship: A Cancer Care Continuum

ICTO 2026 focuses on the evolving landscape of cancer care and the importance of connecting research, clinical practice, and translational approaches across the cancer care continuum.

The conference provides an international platform for oncologists, clinicians, researchers, academicians, healthcare professionals, scientists, and industry experts to exchange knowledge, present research findings, discuss emerging technologies, and explore innovative approaches in cancer care.

Why Attend ICTO 2026?

Participants will have opportunities to:

• Explore recent advances in clinical and translational oncology.
• Share research findings and scientific perspectives.
• Connect with international oncology and healthcare professionals.
• Discuss emerging approaches in cancer prevention, diagnosis, and treatment.
• Exchange ideas on improving patient care and survivorship.
• Build professional and research collaborations.

Conference Details

Conference: 9th Edition of International Conference on Clinical & Translational Oncology (ICTO 2026)
Date: October 8–10, 2026
Location: Tokyo, Japan
Format: Hybrid – In-person & Virtual
Theme: From Prevention to Survivorship: A Cancer Care Continuum

Researchers and professionals interested in oncology and related disciplines are invited to participate and contribute to the scientific discussions at ICTO 2026.

Learn more, register, or submit your abstract:
https://magnusconferences.com/cancer-oncology/

#ICTO2026 #InternationalOncologyConference #CancerResearch #Oncology #ClinicalOncology #TranslationalOncology #CancerCare #MedicalResearch #HealthcareConference #TokyoConference #HybridConference

Catch the Early Bird Advantage at ICTO 2026 – International Conference on Clinical & Translational Oncology

 The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) is scheduled for October 8–10, 2026, in Tokyo, Japan, with virtual participation available through its Hybrid Event format organized by Magnus Group.

ICTO 2026 provides an international platform for clinicians, researchers, healthcare professionals, academics, and oncology experts to exchange knowledge, present research, and explore emerging developments in clinical and translational oncology.

What to Expect at ICTO 2026?

🔬 Latest Oncology Research
Discover emerging research, innovative approaches, and developments shaping the future of oncology.

🌍 International Speakers
Gain insights from experts and professionals working across different areas of oncology and cancer research.

🧬 Scientific Sessions
Explore current developments in clinical and translational oncology through scientific presentations and discussions.

🤝 Global Networking
Connect with researchers, clinicians, healthcare professionals, and experts from around the world.

💡 Knowledge Exchange
Share research findings, experiences, and perspectives while contributing to the global oncology community.

🐦 Catch the Early Bird Advantage!

Participants are encouraged to register early and take advantage of exclusive benefits before the registration deadline.

📅 Date: October 8–10, 2026
📍 Location: Tokyo, Japan
💻 Participation: Hybrid Event – In Person & Virtual

For conference information, visit:
https://magnusconferences.com/cancer-oncology/

📧 Email: cancer@magnusconferences.com
📞 Phone: +1 (702) 988 2320
💬 WhatsApp: +1 (640) 666 9566

Register early and save more!

🎟️ Register Today: https://magnusconferences.com/cancer-oncology/register

#ICTO2026 #ClinicalOncology #TranslationalOncology #OncologyConference #CancerResearch #CancerResearch2026 #MedicalConference #OncologyResearch #HybridConference #TokyoJapan #EarlyBirdRegistration

ICTO 2026: Register Early and Save More on Your Participation

The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) organized by Magnus Group is bringing together oncology professionals, clinicians, researchers, academics, healthcare experts, and industry professionals for three days of scientific exchange and collaboration.

The conference will be held October 8–10, 2026, in Tokyo, Japan, with a hybrid participation option, allowing attendees to participate either in person or virtually.

ICTO 2026 provides an excellent platform to present research, exchange scientific knowledge, discuss emerging developments in oncology, and build valuable professional connections with experts from around the world.

Conference Highlights

• International scientific networking
• Oral and keynote presentations
• Research and knowledge exchange
• Discussions on clinical and translational oncology
• Opportunities for collaboration
• In-person and virtual participation

📅 October 8–10, 2026
📍 Tokyo, Japan | Hybrid Event

Early registration is encouraged to take advantage of available savings.

👉 Register Today: https://magnusconferences.com/cancer-oncology/register

🔗 More Information: https://magnusconferences.com/cancer-oncology/

For further information, contact cancer@magnusconferences.org.

#ICTO2026 #InternationalOncologyConference #ClinicalOncology #TranslationalOncology #CancerResearch #OncologyConference #CancerResearchConference #MedicalConference #TokyoConference #JapanConference

🎗️ ICTO 2026: Register Now for the International Conference on Clinical & Translational Oncology

 The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) is scheduled for 08–10 October 2026 in Tokyo, Japan, with a hybrid participation option, organized by Magnus Group.

This international conference brings together professionals and experts working across clinical oncology, cancer research, translational medicine, healthcare, and related scientific fields.

🌍 Be Part of ICTO 2026

The conference offers an opportunity for participants to present their research, exchange scientific knowledge, establish professional connections, and discuss emerging developments in oncology.

📅 Event Information

Conference: 9th Edition of the International Conference on Clinical & Translational Oncology
Date: 08–10 October 2026
Venue: Tokyo, Japan
Event Format: Hybrid Event

🔬 Who Can Participate?

ICTO 2026 welcomes participation from:

• Oncologists
• Cancer researchers
• Clinicians
• Medical professionals
• Academicians
• Healthcare professionals
• Translational medicine researchers
• Pharmaceutical and biotechnology professionals
• Students and early-career researchers

🎤 Present Your Research

Researchers and professionals can take part by submitting their abstracts for consideration and sharing their scientific work with an international audience.

👉 Submit your abstract: ICTO 2026 Abstract Submission

🌐 Register Now

Whether you plan to attend in person in Tokyo, Japan, or participate online, ICTO 2026 provides an opportunity to connect with the international oncology community.

👉 Register here: https://magnusconferences.com/cancer-oncology/register

For additional conference information, visit: https://magnusconferences.com/cancer-oncology/

📩 Contact: cancer@magnusconference.com

🎗️ Save the Date

08–10 October 2026 | Tokyo, Japan | Hybrid Event

Register now and join the global community advancing clinical and translational oncology.

#ICTO2026 #Oncology #CancerResearch #ClinicalOncology #TranslationalOncology #CancerConference #OncologyConference #CancerResearchConference #MedicalResearch #ClinicalResearch #HealthcareInnovation #CancerCare #Tokyo #Japan #HybridConference #MagnusGroup

Translational and Clinical Cancer Research – ICTO 2026

 The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) organized Magnus Group invites researchers, clinicians, oncologists, healthcare professionals, academics, and industry experts to participate in an international scientific platform dedicated to advancing cancer research.

Translational and Clinical Cancer Research

Cancer research continues to advance through strong collaboration between laboratory discoveries and clinical applications. Translational and clinical research plays a vital role in transforming scientific discoveries into improved approaches for cancer prevention, diagnosis, treatment, and patient care.

Researchers are encouraged to share their latest findings and contribute to the global discussion on the future of cancer research.

📅 Date: October 08–10, 2026
📍 Location: Tokyo, Japan
🌐 Format: Hybrid Event

Submit your research and join the international oncology community at ICTO 2026.

📝 Abstract Submission: https://magnusconferences.com/cancer-oncology/submit-abstract

🔗 More Information: https://magnusconferences.com/cancer-oncology/

#ICTO2026 #TranslationalCancerResearch #ClinicalCancerResearch #CancerResearch #Oncology #ClinicalOncology #TranslationalOncology #CancerConference #CancerResearch2026 #Tokyo #HybridConference

Call for Papers: 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026)

 The 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) organized by Magnus Group invites researchers, clinicians, healthcare professionals, scientists, academicians, and industry experts from across the globe to submit their original research and participate in this prestigious international event.

Scheduled for October 08–10, 2026, in Tokyo, Japan, with hybrid participation options, ICTO 2026 provides an exceptional platform to discuss groundbreaking discoveries, emerging technologies, and innovative therapeutic approaches in clinical and translational oncology.

Why Attend ICTO 2026?

• Present your latest research to an international audience.
• Engage with globally recognized oncology experts.
• Build collaborations with researchers and healthcare professionals.
• Gain valuable scientific feedback.
• Explore recent advancements in cancer diagnosis, treatment, immunotherapy, precision medicine, biomarkers, and translational research.
• Network with academic institutions, hospitals, research organizations, and industry leaders.

Who Should Attend?

• Oncologists
• Cancer Researchers
• Clinical Scientists
• Medical Professionals
• Surgeons
• Pathologists
• Pharmaceutical Researchers
• Healthcare Providers
• Faculty Members
• Students
• Industry Representatives

Submit Your Abstract

Researchers are encouraged to submit original research, case studies, and review presentations.

Abstract Submission
https://magnusconferences.com/cancer-oncology/submit-abstract

Conference Details

📅 October 08–10, 2026

📍 Tokyo, Japan | Hybrid Event

Website:
https://magnusconferences.com/cancer-oncology/

Join ICTO 2026 and contribute to advancing global cancer research while connecting with distinguished experts from around the world.

#ICTO2026 #ClinicalOncology #TranslationalOncology #CancerResearch #CancerConference #MedicalResearch #Oncology #HealthcareInnovation #CallForPapers #Tokyo #HybridConference #MagnusGroup

Abstract Submission Now Open for ICTO 2026

 Are you conducting innovative research in oncology? Here's your opportunity to present your work at the 9th Edition of the International Conference on Clinical & Translational Oncology (ICTO 2026) Organized by Magnus Group.

Join leading oncologists, clinicians, researchers, academicians, and healthcare professionals from around the world to discuss the latest advancements in cancer research and patient care.

Conference Details

📅 Dates: October 08–10, 2026

📍 Venue: Tokyo, Japan

🌐 Format: Hybrid (In-Person & Virtual)

Conference Theme

From Prevention to Survivorship: A Cancer Care Continuum

ICTO 2026 will showcase cutting-edge research, innovative treatment strategies, precision oncology, immunotherapy, translational medicine, and multidisciplinary approaches that are transforming cancer care.

Why Submit Your Abstract?

• Present your research to an international audience.
• Gain recognition among global oncology experts.
• Receive valuable scientific feedback.
• Build collaborations with researchers worldwide.
• Expand your professional network.

Whether you are an experienced researcher or an early-career scientist, ICTO 2026 provides an excellent platform to share your discoveries.

Submit Your Abstract

🔗 https://magnusconferences.com/cancer-oncology/submit-abstract

Conference Website

🔗 https://magnusconferences.com/cancer-oncology/

📧 cancer@magnusconference.com

Join us in Tokyo or participate virtually and contribute to the future of clinical and translational oncology.

Submit your abstract today and be part of ICTO 2026!

#ICTO2026 #Oncology #CancerResearch #ClinicalOncology #TranslationalOncology #CancerConference #MedicalResearch #HealthcareInnovation #AbstractSubmission #HybridConference #Tokyo #CancerCare #ClinicalResearch #MagnusGroup